GL9I Stock Overview
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Glanbia plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €18.17 |
| 52 Week High | €18.17 |
| 52 Week Low | €13.45 |
| Beta | 0.55 |
| 1 Month Change | 4.73% |
| 3 Month Change | n/a |
| 1 Year Change | 34.00% |
| 3 Year Change | 42.51% |
| 5 Year Change | 6.95% |
| Change since IPO | 213.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| GL9I | GB Food | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 1.2% |
| 1Y | 34.0% | 14.7% | -0.3% |
Return vs Industry: GL9I exceeded the UK Food industry which returned 15.9% over the past year.
Return vs Market: GL9I exceeded the UK Market which returned -0.7% over the past year.
Price Volatility
| GL9I volatility | |
|---|---|
| GL9I Average Weekly Movement | n/a |
| Food Industry Average Movement | 3.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: GL9I has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GL9I's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 5,534 | Hugh McGuire | www.glanbia.com |
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Glanbia plc Fundamentals Summary
| GL9I fundamental statistics | |
|---|---|
| Market cap | €4.64b |
| Earnings (TTM) | €326.47m |
| Revenue (TTM) | €5.10b |
14.2x
P/E Ratio0.9x
P/S RatioIs GL9I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GL9I income statement (TTM) | |
|---|---|
| Revenue | US$5.43b |
| Cost of Revenue | US$4.30b |
| Gross Profit | US$1.12b |
| Other Expenses | US$776.50m |
| Earnings | US$347.60m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 20.72% |
| Net Profit Margin | 6.41% |
| Debt/Equity Ratio | 31.1% |
How did GL9I perform over the long term?
See historical performance and comparison